Uncategorized Archives - Page 78 of 87 - PsychedelicNewsWire (PNW)

FridayJan 11, 2019 11:10 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Discusses Company Initiatives at O’Cannabiz 2018

Lexaria Bioscience has its innovative DehydraTECH drug delivery platform The company’s DehydraTECH technology is complementary to other R&D being done on cannabinoids Lexaria recently attended O’Cannabiz 2018 in Vancouver A biotech company, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) offers a unique platform that makes it possible to deliver bioactive substances through oral ingestion. Its DehydraTECH technology accomplishes this without the need for unhealthy inhalational dosing. DehydraTECH uses only GRAS (Generally Recognized as Safe) ingredients and increases bio-absorption by five to 10 times. Based in Kelowna, British Columbia, Lexaria Bioscience is the only company globally with patents issued for the…

TuesdayDec 04, 2018 11:27 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Submits Application for Research License to Health Canada

Lexaria has developed its DehydraTECH technology The company also has four new subsidiaries Lexaria recently submitted its application to Health Canada for a research license Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a research-driven company that has developed and out-licenses its DehydraTECH technology – a drug delivery platform. It is the only company globally with a patent issued for oral delivery of all cannabinoids. The company’s technology facilitates the delivery of bioactive substances via oral ingestion without the need for inhalational dosing or co-administration with sugars or sweeteners. Lexaria Bioscience is headquartered in Kelowna, British Columbia. Lexaria has four…

TuesdayDec 04, 2018 11:06 am

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Keeps its Vision High as Cannabis Prospects Continue to Germinate through Political Changes

U.S. midterm elections signal growing fortunes for cannabis industries with pro-cannabis voting, ouster of anti-cannabis attorney general Phivida among cannabis industry companies that enjoy stock boost in immediate wake of elections Phivida enthused by new FDA and DEA acceptance of natural cannabis in pharmaceuticals, which opens prospects for non-FDA administered products as well Company announces appointment of new senior vice president of distribution to optimize placement of its products in functional food and beverage markets A rolling groundswell of progressive developments in the cannabis use seascape, driven by winds of change in North America’s political arenas, is underscoring the optimism…

WednesdayNov 28, 2018 12:06 pm

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Mobile Hemp Oil Supplement Powder Packet, ChrgD+, Utilizes DehydraTECH Technology

LXRP partners with Cultivating Wellness Inc. (“CW”) to formulate the ChrgD+ premium brand and will now focus on selling it to CW’s national distribution network of retailers The two-gram powder packets are water soluble and can be added to any hot/cold beverage; they are a ready-mix hemp oil supplement that can be added to drinks, such as coffee DehydraTECH has already received multiple patents, and LXRP is a drug delivery platform innovator; the introduction is seen as a first step in the relationship between the companies Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) introduction of ChrgD+ powder packets, which can…

WednesdayNov 14, 2018 12:11 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Grows Stronger with Patents and Third-Party Partners

Improving the quality, taste and effectiveness of cannabis products with DehydraTECH Recently granted two new U.S. patents, with over 50 additional patent applications filed worldwide Applications span a wide range of products as the company out-licenses IP to third-party partners through a royalty model Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is using its DehydraTECH to increase the quality, taste and effectiveness of cannabis products. Lexaria’s revolutionary drug delivery platform is disrupting the way cannabidiol enters the bloodstream. Rather than relying on the traditional methods of inhalation, which has harmful lasting impact on a person’s health, DehydraTECH allows for a…

ThursdayNov 08, 2018 9:45 am

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Private Placement Raises Gross Proceeds of $1.5M; Funds Allocated for Canadian Lab, R&D

Increased size of non-brokered private placement raises gross proceeds of $1,515,440, to be used to fund construction of new Canadian lab, LXRP's R&D and general corporate purposes LXRP has received two new U.S. patents related to cannabinoid infused beverage compositions using DehydraTECH; the company is a drug delivery innovator The company has expanded its IP portfolio, giving it a total of 10 patents in its first family in the U.S. and Australia; it has 50 patent applications globally and out-licenses its technology Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has raised, in a non-brokered private placement, a total of $1,515,440.…

FridayNov 02, 2018 11:31 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Focusing on its New Subsidiaries and Intellectual Property

Lexaria has its patented DehydraTECH drug delivery platform The company’s technology is a complementary layer that works with the other research being done on cannabinoids Lexaria has a robust IP portfolio and four new subsidiary companies A drug delivery platform pioneer, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its DehydraTECH technology. The company’s technology changes the way in which edible cannabinoids absorb into the body. The DehydraTECH drug delivery platform is patented for cannabidiol and all other non-psychoactive cannabinoids and enables the transportation of bioactive substances via oral ingestion. A research-driven enterprise, Lexaria Bioscience is based…

MondayOct 29, 2018 12:21 pm

Earth Science Tech, Inc. (ETST) Taps into Highly Promising CBD Beverage Market

Earth Science Tech plans to enter the CBD beverages market through the development of its own full-spectrum CBD drink The product is developed on the basis of a University of Central Oklahoma Provisional Patent Industry experts predict rapid growth of the CBD beverages market, which is still in the early stages of development and offers excellent opportunities Earth Science Tech, Inc. (OTCQB: ETST) announced that it has started work on the formulation of a full-spectrum CBD beverage. The biotech company that focuses on CBD, pharmaceutical and nutraceutical products will be utilizing its University of Central Oklahoma Provisional Patent to develop…

WednesdayOct 24, 2018 10:37 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives Two US Patents, Bringing Total to 10 in First Patent Family across US and Australia

The two new patents are related to certain cannabinoid-infused beverage compositions using LXRP’s DehydraTECH technology Globally, LXRP has filed some 50 patent applications as the company expands its IP portfolio; LXRP hopes to receive two more granted patents from Australia by year end, giving it 12 in total LXRP out-licenses its technology, which promotes healthier and faster ingestion; the company seeks accelerated patent application examinations in Australia based on the U.S. patents Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has been granted two new U.S. patents based on cannabinoid-infused beverage compositions using its DehydraTECH ingestion technology platform. The company is…

TuesdayOct 16, 2018 11:28 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Completes Establishment of Four Wholly Owned Subsidiaries

Lexaria’s technology changes the manner in which edible cannabinoids enter the body The company out-licenses its DehydraTECH drug delivery platform Lexaria recently announced the creation of four wholly owned subsidiaries A research-driven company, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is the only company globally that has been awarded a patent for the improved delivery of all cannabinoids. It has developed and out-licenses its DehydraTECH technology – a drug delivery platform. This technology is a complementary layer that works with other research and development being conducted on cannabinoids and, as such, is an enabling technology, not a competing one. Lexaria…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Uncategorized